Onderneming Checkmate Pharmaceuticals, Inc.
Aandelen
CMPI
US1628181083
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 31
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Landry
DFI | Director of Finance/CFO | 60 | 31-05-22 |
Chris French
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-16 |
James Wooldridge
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-10-19 |
Nouhad Husseini
BRD | Director/Board Member | - | 31-05-22 |
Kleem Chaudhary
PRN | Corporate Officer/Principal | 48 | 01-11-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nouhad Husseini
BRD | Director/Board Member | - | 31-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 22 038 218 | 21 017 113 ( 95,37 %) | 0 | 95,37 % |
Bedrijfsgegevens
Checkmate Pharmaceuticals, Inc.
245 Main Street 2nd floor
02142, Cambridge
+
http://www.checkmatepharma.com/![Adres Checkmate Pharmaceuticals, Inc.(CMPI)](https://cdn.zonebourse.com/static/address/110594700.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,19% | 121 mld. | |
+19,91% | 114 mld. | |
+8,24% | 23,61 mld. | |
-19,80% | 20,43 mld. | |
-16,19% | 16,55 mld. | |
-13,45% | 16,45 mld. | |
-44,35% | 15,59 mld. | |
+66,67% | 15,19 mld. | |
+2,13% | 13,54 mld. |